Vector Laboratories

When Vector Laboratories was founded more than 25 years ago, monoclonal antibodies, biotin-avidin products or lines of lectins were not available in the marketplace. In 1976, we purified the first line of lectins and quickly became the world’s leading supplier of these products for use in studying glycoconjugates in tissues, on cells, or isolated from fluids or extracts. In our second year we introduced the Biotin-Avidin System. Realizing that the strong interaction between biotin and avidin could be utilized to form nearly covalent linkages between a molecule derivatized with biotin and avidin conjugated with a detectable label, we provided the research community with the first set of Biotin-Avidin System reagents. These first products, consisting of biotinylated proteins and avidin conjugates, began a revolution in detection methods. Our biotinylated anti-mouse immunoglobulin and labeled avidin proved to be the most widely used reagents for detecting and characterizing monoclonal antibodies. After several years, other companies recognized their importance and began offering their own versions of these products. More than ten years ago, we developed and patented processes that enabled complexes between avidin or streptavidin and biotinylated enzymes, designated ABC’s, to be formed. This achievement established the basis for the VECTASTAIN®ABC family of products. While other detection systems produced faint or diffuse staining in tissue sections and required high concentrations of primary antibodies, the VECTASTAIN®ABC system gave dark, discrete, background-free staining with extremely low concentrations of primary anti-bodies. Improvements over the years led to the VECTASTAIN®Elite ABC - widely recognized today as the most sensitive, reliable and economical peroxidase-based staining system available.

Contact Details: 30 Ingold Road Burlingame California 94010 United States of America Tel: (650) 697-3600 Fax: (650) 697-0339 Email: vector@vectorlabs.com WWW: www.vectorlabs.com/

Loading...

BioNews Results for Vector Laboratories:
Step Study Published: HIV Vaccine Does Not Protect Against HIV-1 Infection	Medscape:  Nov 13 2008 12:14AM Matching: vector laboratories
Examine the RNA Interference in the Post-Genomic Era: Markets and Technologies	Business Wire via Yahoo!:  Nov 13 2008 11:33AM Matching: vector laboratories
Examine the RNA Interference in the Post-Genomic Era: Markets and Technologies	Forbes.com:  Nov 13 2008 11:36AM Matching: vector laboratories
Stem cells and their use in transplantation	PharmCast:  Nov 7 2008 12:52PM Matching: vector laboratories
Vaccine for house dust mite allergen using naked DNA	PharmCast:  Nov 4 2008 4:51AM Matching: vector laboratories
Promote your company here: BioNewsCast - Press Release Distribution	→View more Vector Laboratories news.

Vector Laboratories Patents:
US Patent No.	Title
5854409	Pro-thiol aryl azide labelling of nucleic acids
5700921	Labeling nucleic acids
4684609	Method and substance for the enhanced labelling of cellular material

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 206 times since April 2007, the link to the organisation's website has been followed 45 times

Recent Search Terms used to find this page: vector labs | vector laboratories -national -gene | vector laboratories -national -gene | biotin labeling | biotin labeling | .

Search for more companies in Burlingame

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Vector Laboratories